The vision of saniva diagnostics GmbH is the development of a motor screening instrument to enable adequate preventive examination in the field of neurodegenerative diseases. The innovative solution of an inexpensive, standardized screening examination that can be carried out in a short time, is designed to be widely deployable and to identify high risk patients at an early stage. This implies that the ambulatory sector is the appropriate target. Without early detection, there is no sufficient opportunity for the application of neuroprotective drugs or other possible curative therapies. Therefore, early examinations and diagnostics are particularly important, to allow various therapeutic options to be applied earlier in the future.

The technology of saniva diagnostics GmbH will enable for the first time to identify patients earlier and to start therapy at an earlier stage. The screening instrument lays the foundation for the application of innovative therapy methods that cannot be used according to the current state of the art because patients are identified too late. Thus, saniva diagnostics GmbH is not only opening a new market, the company is operating at the cutting edge of research and the health care market.